Robert Phillip Meyer , FNP-C
Nurse Practitioner - Family โข Converse, TX
9135 Schaefer Rd Ste 4
Converse, TX 781091980
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Robert Meyer is listed in NPPES under Nurse Practitioner - Family.
-
NPI assigned on June 13, 2016; this date does not establish years in practice.
-
Published CMS data list 122 Original Medicare Part B services in 2018.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018. Published rows only; this is not a quality measure.
-
Published Part B service records, 2018:
- 99214 โ Established patient outpatient office visit: 122 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2017 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2018). CPT notice
See the full table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 2,701 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Amlodipine Besylate โ 231 prescription fills, including refills.
- Atorvastatin Calcium โ 219 prescription fills, including refills.
- Fluticasone Propionate โ 190 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 62 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 85% of clinicians listed under Nurse Practitioner - Family in Texas (2024, 9,969 clinicians with data). Median for this group: 357. Middle half: 83 to 1,366.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 108 in 2017 to 122 in 2018.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2017โ2018.
Practice Location & Contact Primary Location
9135 Schaefer Rd Ste 4
Converse, TX 781091980
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner - Family: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $11,263 in 2018
The total amount Medicare approved for these services in 2018. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018.
Paid by Medicare
About $7,536 in 2018
The part of the Medicare-allowed amount that Medicare itself paid in 2018, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2018.
30-day fills
5,794 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$362,295 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $3,871.72 across 66 records.
By nature of payment
- Food and Beverage: $3,871.72 across 66 records.
Reporting-company totals (3 largest of 17)
- Bayer Healthcare Pharmaceuticals Inc.: $474.67 across 15 records.
- Novo Nordisk Inc: $439.29 across 8 records.
- Axsome Therapeutics, Inc.: $409.68 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Robert Meyer has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Robert Meyer as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Converse and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Nurse Practitioner - Family in Texas (2024, 9,969 clinicians with data). Median for this group: 357. Middle half: 83 to 1,366.
Too few clinicians listed under Nurse Practitioner - Family in Converse have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner - Family in Texas (2024, 9,969 clinicians with data). Median for this group: $15,967. Middle half: $1,074 to $125,277.
Too few clinicians listed under Nurse Practitioner - Family in Converse have Medicare Part D data for 2024 to compare.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Robert Meyer are from 2018.
9 active clinicians are listed under Nurse Practitioner - Family with a practice address in Converse, TX (21,278 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 13% from 108 in 2017 to 122 in 2018.
- 2017: 108
- 2018: 122
-
Medicare-allowed amount
Medicare-allowed amount increased 29% from $8,740 in 2017 to $11,263 in 2018.
- 2017: $8,740
- 2018: $11,263
-
Paid by Medicare
Paid by Medicare increased 48% from $5,104 in 2017 to $7,536 in 2018.
- 2017: $5,104
- 2018: $7,536
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 80% from 1,500 in 2020 to 2,701 in 2024.
- 2020: 1,500
- 2021: 1,462
- 2022: 1,767
- 2023: 2,448
- 2024: 2,701
-
30-day fills
30-day fills increased 91% from 3,027 in 2020 to 5,794 in 2024.
- 2020: 3,027
- 2021: 3,053
- 2022: 3,871
- 2023: 5,570
- 2024: 5,794
-
Part D drug cost
Part D drug cost increased 74% from $208,015 in 2020 to $362,295 in 2024.
- 2020: $208,015
- 2021: $178,320
- 2022: $283,015
- 2023: $380,896
- 2024: $362,295
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 29% from $2,997.71 in 2021 to $3,871.72 in 2025.
- 2021: $2,997.71
- 2022: $4,640.02
- 2023: $3,444.53
- 2024: $4,361.49
- 2025: $3,871.72
Sources: CMS Medicare Physician & Other Practitioners (2018), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 66 records totaling $3,871.72.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $148.69 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $131.83 |
| Alkermes, Inc. |
Food and Beverage
In-kind items and services
|
LYBALVI | General | $130.00 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $126.33 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $125.00 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
ZEPBOUND | General | $124.99 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $124.99 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $124.99 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $124.99 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $124.99 |
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
JARDIANCE | General | $124.98 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $124.98 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $124.98 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $124.98 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $124.98 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $124.98 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $124.82 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $124.69 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
PENMENVY | General | $120.81 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $120.56 |
| Radius Health, Inc. |
Food and Beverage
In-kind items and services
|
Tymlos | General | $120.55 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $119.76 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
AMS 700 | General | $118.36 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $110.09 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
AREXVY | General | $102.72 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2017 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2018; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
122 | 52 | $106.15 | $92.32 |
Source: CMS Part B by Provider and Service, 2018; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 231 | 17,038 | $2,127.34 | 60 |
| Atorvastatin Calcium | Atorvastatin Calcium | 219 | 16,546 | $2,622.28 | 77 |
| Fluticasone Propionate | Fluticasone Propionate | 190 | 6,960 | $3,806.83 | 55 |
| Losartan Potassium | Losartan Potassium | 160 | 12,227 | $1,668.66 | 56 |
| Metformin Hcl | Metformin Hcl | 118 | 9,716 | $934.75 | 42 |
| Carvedilol | Carvedilol | 111 | 8,460 | $1,056.61 | 34 |
| Lisinopril | Lisinopril | 105 | 9,251 | $786.35 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 96 | 8,505 | $910.76 | 35 |
| Gabapentin | Gabapentin | 80 | 4,046 | $2,038.76 | 20 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 73 | 5,771 | $954.45 | 33 |
| Farxiga | Dapagliflozin Propanediol | 71 | 4,650 | $88,012.61 | 23 |
| Montelukast Sodium | Montelukast Sodium | 69 | 4,950 | $1,170.24 | 24 |
| Trulicity | Dulaglutide | 60 | 1,792 | $60,131.26 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 59 | 1,989 | $1,171.06 | 19 |
| Ozempic | Semaglutide | 57 | 1,700 | $57,184.91 | 12 |
| Levothyroxine Sodium | Levothyroxine Sodium | 55 | 4,770 | $672.48 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 47 | 3,510 | $964.94 | 18 |
| Pantoprazole Sodium | Pantoprazole Sodium | 45 | 2,503 | $909.30 | โ |
| Omeprazole | Omeprazole | 44 | 3,130 | $902.07 | 13 |
| Ezetimibe | Ezetimibe | 41 | 2,750 | $505.08 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 38 | 2,235 | $334.98 | 15 |
| Olanzapine | Olanzapine | 37 | 1,362 | $865.40 | โ |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | 1,867 | $3,800.17 | โ |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | 2,730 | $246.31 | 12 |
| Irbesartan | Irbesartan | 31 | 2,530 | $556.36 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363LF0000X
NUCC Taxonomy Code: 163WG0000X
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20160824000728
TX
7911292370
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Physician Assistant - Medical
PHYSICIANASSISTANT
General Practice
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Family Nurse Practitioner (Board Certified)
Dentist - General Practice
Doctor of Dental Surgery
Dentist - General Practice
Doctor of Dental Surgery
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 9135 SCHAEFER RD STE 4, CONVERSE, TX 781091980 (Tel: 2109227000)
Registered at 3750 COMMERCIAL AVE, SAN ANTONIO, TX 782213117 (Tel: 2103343715)
NPI status registered as active in NPPES database
Registered at 9135 SCHAEFER RD, 4, CONVERSE, TX 781091979 (Tel: 2102815507)
Registered at 9135 SCHAEFER RD, 4, CONVERSE, TX 781091979 (Tel: 2102815507)
Recorded as ROBERT MEYER, FNP-C
Registered Nurse (license number reported to NPPES: TX 722655)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioner - Family Specialists in Converse
Mailing Address
3750 Commercial Ave
San Antonio, TX 782213117
Phone: 2109227000